NTMir’s mission is to save and improve lives through research, education, early detection, and improved treatments for people with pulmonary nontuberculous mycobacterial infection (NTM disease).

Latest News

View More

FDA Workshop on the Development of Antibiotic Therapies for NTM

The FDA workshop on “The Development of Antibiotics for the Treatment of NTM Disease” on April 8, 2019 was very successful, with more than 100 people attending...
Read More

NTM Patient Preferences Survey

On April 8th, 2019 the U.S. Food & Drug Administration will host a public workshop on the development of antibacterial drugs for the treatment of nontuberculous mycobacterial...
Read More

Corporate Sponsor

Stay Informed

Sign up for NTMir's news releases